Related Experiment Videos
Aggressive surgical management of craniopharyngiomas in children
H J Hoffman1, M De Silva, R P Humphreys
1Division of Neurosurgery, Hospital for Sick Children, Toronto, Ontario, Canada.
Insights
This study reviewed 50 pediatric craniopharyngioma surgeries. Most patients achieved good outcomes, but tumor recurrence and long-term deficits like memory and vision issues require ongoing management.
Area of Science:
- Pediatric Neurosurgery
- Pediatric Oncology
- Endocrinology
Background:
- Craniopharyngioma is a rare brain tumor affecting children.
- Symptoms often include headaches, endocrine deficiencies, and visual problems.
- Surgical outcomes in pediatric patients require long-term evaluation.
Purpose of the Study:
- To review surgical outcomes for pediatric craniopharyngioma.
- To assess tumor recurrence rates and long-term patient function.
- To identify common presenting symptoms and postoperative challenges.
Main Methods:
- Retrospective review of 50 pediatric craniopharyngioma cases.
- Surgical procedures included total or subtotal tumor excision.
- Follow-up data analyzed for tumor recurrence, patient survival, and functional status.
Main Results:
- 45 patients had total excision, 5 had subtotal excision.
- Tumor recurrence occurred in 17 patients (mean 32.6 months post-surgery).
- Of 46 followed patients, 28 had near-normal lives, 12 functioned reasonably well, 4 had significant handicaps, and 2 died.
Conclusions:
- Surgical management of pediatric craniopharyngioma can lead to favorable outcomes.
- Endocrine replacement and management of neurological deficits are crucial long-term.
- Ongoing monitoring is necessary due to the risk of recurrence and potential for long-term sequelae.
Abstract:
The cases of 50 patients with craniopharyngioma operated on at The Hospital for Sick Children in Toronto between January, 1975, and December, 1989, are reviewed. All patients were under 18 years of age (mean 9.39 years). Headaches, endocrine deficiencies, and visual deficits were the most common symptoms on admission. Forty-five patients underwent what was considered by the surgeon to be total excision of their tumor, and five had subtotal excision. Tumors recurred in 17 patients (mean time of recurrence 32.6 months after surgery). One patient died in the postoperative period and three have been lost to follow-up study. Of the remaining 46 patients, 28 are leading a normal or nearly normal life, although all are receiving endocrine replacement and some have required help to overcome mild deficits in memory or visual acuity. Twelve patients are able to function reasonably well and attend school despite being hampered by intellectual or visual deficits or problems with weight control; four have a significant handicap, and two have died.